Emergent BioSolutions, Inc. (EBS)
7.995
-0.08
(-1.05%)
USD |
NYSE |
Mar 18, 15:59
8.01
+0.02
(+0.19%)
After-Hours: 18:18
Emergent BioSolutions Market Cap : 413.91M for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 105.79B |
| Eli Lilly & Co. | 819.62B |
| Penumbra, Inc. | 13.29B |
| Disc Medicine, Inc. | 2.258B |
| MetaVia, Inc. | 37.08M |
Market Cap Related Metrics
| PE Ratio | 9.638 |
| PS Ratio | 0.5930 |
| Price to Book Value | 0.7920 |
| Price to Free Cash Flow | 2.809 |
| Price | 7.995 |
| Earnings Yield | 10.38% |
| Operating PE Ratio | 4.030 |
| Normalized PE Ratio | 7.064 |